Mass tort settlement news this week centers on a landmark Supreme Court hearing that could reshape thousands of Roundup cancer claims. The week of April 27, 2026, brought pivotal developments across pharmaceutical, environmental, and consumer product litigation. From courtroom milestones to fast-growing MDLs, affected individuals should track these updates closely. Readers unfamiliar with these cases can review our guide on what is a mass tort for background.
Pharmaceutical Mass Tort Settlement News This Week
The Depo-Provera MDL continues to be one of the fastest-growing mass torts in the country. As of late April, over 3,769 lawsuits are consolidated in the Northern District of Florida. Judge M. Casey Rodgers has scheduled general causation hearings for June 24 through 26. The FDA added a meningioma warning to the Depo-Provera label in December 2025. Five bellwether cases have been selected. The first trial is set for December 7, 2026.
Meanwhile, the Ozempic and GLP-1 litigation reached 3,546 cases across two separate MDLs. One MDL focuses on gastroparesis claims. The other addresses vision loss from NAION. Judge Karen Marston has scheduled a Science Day for June 2, 2026. In addition, the FDA issued a warning letter to Novo Nordisk for late reporting of serious adverse events. No global settlement has been announced yet.
Zantac mass tort settlement news also advanced this week. A Delaware judge ruled that GSK, Pfizer, and other manufacturers must face state court trials. However, a Chicago jury found that Zantac was not responsible for one plaintiff’s colon cancer. These mixed results highlight the uncertainty that still surrounds this litigation. Affected individuals may qualify for potential recovery and should consult a licensed attorney.
Medical Device Lawsuit Developments
The hernia mesh litigation remains one of the largest medical device MDLs in federal court. CR Bard faces 23,695 lawsuits in MDL 2846. Covidien has over 2,348 cases pending. The first Covidien bellwether trial began in February 2026 in Boston. A second bellwether is scheduled for July 13, 2026. Attorneys expect Covidien cases to yield higher settlement amounts due to the severity of injuries alleged.
In addition, mass tort settlement news in the medical device space includes the 3M Combat Arms earplug resolution. That MDL has been completely dismissed as of late April. The $6 billion settlement resolved one of the largest military product liability cases in U.S. history. For example, over 300,000 veterans filed claims in that litigation. For a full list of active cases, visit our active MDL cases tracker.
Environmental Contamination Case Updates
The most significant mass tort settlement news this week came from the Supreme Court. On April 27, the justices heard oral arguments in Monsanto v. Durnell. This case will determine whether federal pesticide law preempts state failure-to-warn claims. A ruling in Bayer’s favor could shield the company from future Roundup lawsuits. The decision is expected before the court’s term ends in June 2026.
However, Bayer still faces roughly 58,000 active Roundup cancer claims. The company has already settled over 100,000 cases for approximately $11 billion. Meanwhile, the Camp Lejeune water contamination litigation reached a troubling milestone. The DOJ has paid $421 million in settlements since January 2025. Yet only 2,353 of more than 400,000 claims have been resolved. That represents a resolution rate of less than 1%.
The AFFF firefighting foam litigation also saw continued movement. Over 15,200 lawsuits remain pending in South Carolina federal court. A $1.185 billion settlement from DuPont, Chemours, and Corteva was approved. Attorneys handling PFAS cases expect additional settlement announcements soon. Understanding how mass tort settlements work can help claimants prepare for what comes next.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Consumer Product Litigation News
Johnson & Johnson confirmed it will not appeal its third bankruptcy dismissal in the talcum powder litigation. This mass tort settlement news is significant for the roughly 67,000 pending claims in MDL 2738. The decision returns all cases to traditional court proceedings. Congress also reintroduced bills targeting the “Texas two-step” bankruptcy strategy. A March 2026 federal jury awarded $50 million in one mesothelioma case. However, a Los Angeles judge vacated $950 million in punitive damages in a separate matter.
The hair relaxer MDL now includes 11,526 lawsuits. Discovery for first-wave defendants is largely complete. The judge selected 10 bellwether cases that best represent the injuries in the litigation. As a result, bellwether trials are expected to begin in 2027. No settlements have occurred yet in this MDL. Affected individuals should consult a licensed attorney to understand their options.
Mass tort settlement news in consumer product cases also includes the social media youth harm litigation. MDL 3047 now has 2,527 pending actions. A California judge denied motions to exclude expert witnesses ahead of the first bellwether trial. Snapchat recently reached a last-minute settlement in a California state court case. The first federal bellwether trial is set for June 15, 2026. For state-by-state differences in how these claims are handled, see our tort reform by state comparison.
Key Deadlines and What to Watch
Several important dates are approaching for mass tort settlement news watchers. The Ozempic NAION Science Day is June 2, 2026. The social media bellwether trial begins June 15. The Depo-Provera general causation hearings start June 24. The Supreme Court’s Roundup ruling is expected by late June. The second Covidien hernia mesh bellwether trial starts July 13.
As a result, the next two months could reshape several major mass tort cases. Readers who believe they may be affected should use our eligibility quiz to check their options. We always recommend consulting a licensed attorney for personalized guidance. For past coverage, visit our settlement news archive. This week’s mass tort settlement news underscores the rapid pace of developments across federal courts nationwide.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- California Tort Reform Guide
- Pennsylvania Tort Reform Guide
- North Carolina Tort Reform Guide
You May Also Like
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.